Ethema Health Corporation
Ethema Health Corporation GRST Peers
See (GRST) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GRST | $0.00 | +0.00% | 2.3M | N/A | N/A | N/A |
| FSNUY | $11.93 | +0.42% | 107.6B | 21.70 | $0.55 | +2.31% |
| FSNUF | $46.21 | +0.00% | 26B | 21.00 | $2.20 | +2.28% |
| KONEF | $0.00 | +0.00% | 22.2B | -0.12 | -$0.04 | N/A |
| JDHIY | $5.10 | +0.00% | 18.2B | 31.61 | $0.18 | N/A |
| FMCQF | $53.61 | +0.00% | 13.8B | 19.03 | $2.48 | +3.46% |
| BDUUY | $32.33 | +0.00% | 12.8B | 28.30 | $1.14 | +2.79% |
| JDHIF | $6.27 | -0.02% | 11.7B | 30.42 | $0.12 | N/A |
| BDULF | $0.61 | +0.00% | 9.8B | 20.47 | $0.03 | +3.61% |
| IHHHF | $1.19 | +0.00% | 9.7B | 15.71 | $0.07 | +5.28% |
Stock Comparison
GRST vs FSNUY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, FSNUY has a market cap of 107.6B. Regarding current trading prices, GRST is priced at $0.00, while FSNUY trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas FSNUY's P/E ratio is 21.70. In terms of profitability, GRST's ROE is +0.30%, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, GRST is less volatile compared to FSNUY. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs FSNUF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, FSNUF has a market cap of 26B. Regarding current trading prices, GRST is priced at $0.00, while FSNUF trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas FSNUF's P/E ratio is 21.00. In terms of profitability, GRST's ROE is +0.30%, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, GRST and FSNUF have similar daily volatility (0.00).
GRST vs KONEF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, KONEF has a market cap of 22.2B. Regarding current trading prices, GRST is priced at $0.00, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas KONEF's P/E ratio is -0.12. In terms of profitability, GRST's ROE is +0.30%, compared to KONEF's ROE of -6.56%. Regarding short-term risk, GRST and KONEF have similar daily volatility (0.00).
GRST vs JDHIY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, JDHIY has a market cap of 18.2B. Regarding current trading prices, GRST is priced at $0.00, while JDHIY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas JDHIY's P/E ratio is 31.61. In terms of profitability, GRST's ROE is +0.30%, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, GRST and JDHIY have similar daily volatility (0.00).
GRST vs FMCQF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, FMCQF has a market cap of 13.8B. Regarding current trading prices, GRST is priced at $0.00, while FMCQF trades at $53.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas FMCQF's P/E ratio is 19.03. In terms of profitability, GRST's ROE is +0.30%, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, GRST and FMCQF have similar daily volatility (0.00).
GRST vs BDUUY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, GRST is priced at $0.00, while BDUUY trades at $32.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BDUUY's P/E ratio is 28.30. In terms of profitability, GRST's ROE is +0.30%, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, GRST and BDUUY have similar daily volatility (0.00).
GRST vs JDHIF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, JDHIF has a market cap of 11.7B. Regarding current trading prices, GRST is priced at $0.00, while JDHIF trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas JDHIF's P/E ratio is 30.42. In terms of profitability, GRST's ROE is +0.30%, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, GRST and JDHIF have similar daily volatility (0.00).
GRST vs BDULF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BDULF has a market cap of 9.8B. Regarding current trading prices, GRST is priced at $0.00, while BDULF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BDULF's P/E ratio is 20.47. In terms of profitability, GRST's ROE is +0.30%, compared to BDULF's ROE of +0.16%. Regarding short-term risk, GRST and BDULF have similar daily volatility (0.00).
GRST vs IHHHF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, IHHHF has a market cap of 9.7B. Regarding current trading prices, GRST is priced at $0.00, while IHHHF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, GRST's ROE is +0.30%, compared to IHHHF's ROE of +0.08%. Regarding short-term risk, GRST and IHHHF have similar daily volatility (0.00).
GRST vs BDUUF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BDUUF has a market cap of 9.6B. Regarding current trading prices, GRST is priced at $0.00, while BDUUF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BDUUF's P/E ratio is 20.12. In terms of profitability, GRST's ROE is +0.30%, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, GRST and BDUUF have similar daily volatility (0.00).
GRST vs RMSYF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RMSYF has a market cap of 5.8B. Regarding current trading prices, GRST is priced at $0.00, while RMSYF trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RMSYF's P/E ratio is 505.00. In terms of profitability, GRST's ROE is +0.30%, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, GRST and RMSYF have similar daily volatility (0.00).
GRST vs RMYHY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RMYHY has a market cap of 4.9B. Regarding current trading prices, GRST is priced at $0.00, while RMYHY trades at $6.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RMYHY's P/E ratio is 535.00. In terms of profitability, GRST's ROE is +0.30%, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, GRST and RMYHY have similar daily volatility (0.00).
GRST vs BUHPF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BUHPF has a market cap of 4.7B. Regarding current trading prices, GRST is priced at $0.00, while BUHPF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BUHPF's P/E ratio is 25.67. In terms of profitability, GRST's ROE is +0.30%, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, GRST and BUHPF have similar daily volatility (0.00).
GRST vs ANHGY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, GRST is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, GRST's ROE is +0.30%, compared to ANHGY's ROE of N/A. Regarding short-term risk, GRST and ANHGY have similar daily volatility (0.00).
GRST vs BUGDF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BUGDF has a market cap of 3.4B. Regarding current trading prices, GRST is priced at $0.00, while BUGDF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BUGDF's P/E ratio is 16.35. In terms of profitability, GRST's ROE is +0.30%, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, GRST is less volatile compared to BUGDF. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs RHCGF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RHCGF has a market cap of 3.2B. Regarding current trading prices, GRST is priced at $0.00, while RHCGF trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RHCGF's P/E ratio is -8.18. In terms of profitability, GRST's ROE is +0.30%, compared to RHCGF's ROE of -0.07%. Regarding short-term risk, GRST and RHCGF have similar daily volatility (0.00).
GRST vs MCVEY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MCVEY has a market cap of 2.8B. Regarding current trading prices, GRST is priced at $0.00, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MCVEY's P/E ratio is 52.54. In terms of profitability, GRST's ROE is +0.30%, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, GRST and MCVEY have similar daily volatility (0.00).
GRST vs MCVEF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MCVEF has a market cap of 2.7B. Regarding current trading prices, GRST is priced at $0.00, while MCVEF trades at $19.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MCVEF's P/E ratio is 75.00. In terms of profitability, GRST's ROE is +0.30%, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, GRST and MCVEF have similar daily volatility (0.00).
GRST vs JXFGF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, JXFGF has a market cap of 2.7B. Regarding current trading prices, GRST is priced at $0.00, while JXFGF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas JXFGF's P/E ratio is 50.00. In terms of profitability, GRST's ROE is +0.30%, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, GRST and JXFGF have similar daily volatility (0.00).
GRST vs TTALF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, GRST is priced at $0.00, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas TTALF's P/E ratio is 19.33. In terms of profitability, GRST's ROE is +0.30%, compared to TTALF's ROE of +0.15%. Regarding short-term risk, GRST and TTALF have similar daily volatility (0.00).
GRST vs LTGHF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, LTGHF has a market cap of 1.5B. Regarding current trading prices, GRST is priced at $0.00, while LTGHF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas LTGHF's P/E ratio is 14.43. In terms of profitability, GRST's ROE is +0.30%, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, GRST and LTGHF have similar daily volatility (0.00).
GRST vs RYHTY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RYHTY has a market cap of 1.4B. Regarding current trading prices, GRST is priced at $0.00, while RYHTY trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RYHTY's P/E ratio is -3.77. In terms of profitability, GRST's ROE is +0.30%, compared to RYHTY's ROE of -0.02%. Regarding short-term risk, GRST and RYHTY have similar daily volatility (0.00).
GRST vs RAFLF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RAFLF has a market cap of 1.4B. Regarding current trading prices, GRST is priced at $0.00, while RAFLF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RAFLF's P/E ratio is 25.00. In terms of profitability, GRST's ROE is +0.30%, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, GRST and RAFLF have similar daily volatility (0.00).
GRST vs LWSCF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, LWSCF has a market cap of 1.3B. Regarding current trading prices, GRST is priced at $0.00, while LWSCF trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas LWSCF's P/E ratio is 45.93. In terms of profitability, GRST's ROE is +0.30%, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, GRST and LWSCF have similar daily volatility (0.00).
GRST vs LTGHY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, LTGHY has a market cap of 1.2B. Regarding current trading prices, GRST is priced at $0.00, while LTGHY trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas LTGHY's P/E ratio is -21.07. In terms of profitability, GRST's ROE is +0.30%, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, GRST is less volatile compared to LTGHY. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs RHKJF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, GRST is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, GRST's ROE is +0.30%, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, GRST and RHKJF have similar daily volatility (0.00).
GRST vs RKAGY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RKAGY has a market cap of 986.7M. Regarding current trading prices, GRST is priced at $0.00, while RKAGY trades at $7.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RKAGY's P/E ratio is 21.06. In terms of profitability, GRST's ROE is +0.30%, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, GRST and RKAGY have similar daily volatility (0.00).
GRST vs NWKHY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NWKHY has a market cap of 960.7M. Regarding current trading prices, GRST is priced at $0.00, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NWKHY's P/E ratio is 11.47. In terms of profitability, GRST's ROE is +0.30%, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, GRST and NWKHY have similar daily volatility (0.00).
GRST vs WHTCF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, WHTCF has a market cap of 873.3M. Regarding current trading prices, GRST is priced at $0.00, while WHTCF trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas WHTCF's P/E ratio is -43.12. In terms of profitability, GRST's ROE is +0.30%, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, GRST and WHTCF have similar daily volatility (0.00).
GRST vs EXETF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, EXETF has a market cap of 796.3M. Regarding current trading prices, GRST is priced at $0.00, while EXETF trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas EXETF's P/E ratio is 14.62. In terms of profitability, GRST's ROE is +0.30%, compared to EXETF's ROE of +0.66%. Regarding short-term risk, GRST is less volatile compared to EXETF. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs KDGTF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, GRST is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, GRST's ROE is +0.30%, compared to KDGTF's ROE of N/A. Regarding short-term risk, GRST and KDGTF have similar daily volatility (0.00).
GRST vs WFHG Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, WFHG has a market cap of 471.2M. Regarding current trading prices, GRST is priced at $0.00, while WFHG trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas WFHG's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to WFHG's ROE of +0.22%. Regarding short-term risk, GRST and WFHG have similar daily volatility (0.00).
GRST vs ORRRY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, GRST is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, GRST's ROE is +0.30%, compared to ORRRY's ROE of +0.91%. Regarding short-term risk, GRST and ORRRY have similar daily volatility (0.00).
GRST vs BTMDW Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, GRST is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, GRST's ROE is +0.30%, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, GRST is less volatile compared to BTMDW. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs ORPEF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ORPEF has a market cap of 242M. Regarding current trading prices, GRST is priced at $0.00, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ORPEF's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to ORPEF's ROE of -0.16%. Regarding short-term risk, GRST and ORPEF have similar daily volatility (0.00).
GRST vs MKLNF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, GRST is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, GRST's ROE is +0.30%, compared to MKLNF's ROE of +0.14%. Regarding short-term risk, GRST and MKLNF have similar daily volatility (0.00).
GRST vs MFCSF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MFCSF has a market cap of 197M. Regarding current trading prices, GRST is priced at $0.00, while MFCSF trades at $10.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MFCSF's P/E ratio is 6.71. In terms of profitability, GRST's ROE is +0.30%, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, GRST and MFCSF have similar daily volatility (0.00).
GRST vs MDGP Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MDGP has a market cap of 174.5M. Regarding current trading prices, GRST is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MDGP's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to MDGP's ROE of -2.19%. Regarding short-term risk, GRST and MDGP have similar daily volatility (0.00).
GRST vs COLRF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, COLRF has a market cap of 143.5M. Regarding current trading prices, GRST is priced at $0.00, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas COLRF's P/E ratio is -8.00. In terms of profitability, GRST's ROE is +0.30%, compared to COLRF's ROE of +0.02%. Regarding short-term risk, GRST and COLRF have similar daily volatility (0.00).
GRST vs CHHHF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, CHHHF has a market cap of 129.2M. Regarding current trading prices, GRST is priced at $0.00, while CHHHF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas CHHHF's P/E ratio is -51.25. In terms of profitability, GRST's ROE is +0.30%, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, GRST and CHHHF have similar daily volatility (0.00).
GRST vs TOKIF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, GRST is priced at $0.00, while TOKIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, GRST's ROE is +0.30%, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, GRST and TOKIF have similar daily volatility (0.00).
GRST vs VTIAF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, VTIAF has a market cap of 95.9M. Regarding current trading prices, GRST is priced at $0.00, while VTIAF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas VTIAF's P/E ratio is -6.79. In terms of profitability, GRST's ROE is +0.30%, compared to VTIAF's ROE of -0.63%. Regarding short-term risk, GRST and VTIAF have similar daily volatility (0.00).
GRST vs EVGRF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, EVGRF has a market cap of 85.4M. Regarding current trading prices, GRST is priced at $0.00, while EVGRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas EVGRF's P/E ratio is -0.01. In terms of profitability, GRST's ROE is +0.30%, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, GRST and EVGRF have similar daily volatility (0.00).
GRST vs MCIOF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, GRST is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, GRST's ROE is +0.30%, compared to MCIOF's ROE of N/A. Regarding short-term risk, GRST and MCIOF have similar daily volatility (0.00).
GRST vs ASSF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, GRST is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ASSF's P/E ratio is -33.33. In terms of profitability, GRST's ROE is +0.30%, compared to ASSF's ROE of -6.63%. Regarding short-term risk, GRST and ASSF have similar daily volatility (0.00).
GRST vs USNU Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, GRST is priced at $0.00, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas USNU's P/E ratio is -9.41. In terms of profitability, GRST's ROE is +0.30%, compared to USNU's ROE of -0.62%. Regarding short-term risk, GRST is less volatile compared to USNU. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs HQDA Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, GRST is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas HQDA's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to HQDA's ROE of +0.00%. Regarding short-term risk, GRST and HQDA have similar daily volatility (0.00).
GRST vs NVLPF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NVLPF has a market cap of 17.3M. Regarding current trading prices, GRST is priced at $0.00, while NVLPF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NVLPF's P/E ratio is 19.79. In terms of profitability, GRST's ROE is +0.30%, compared to NVLPF's ROE of +0.05%. Regarding short-term risk, GRST and NVLPF have similar daily volatility (0.00).
GRST vs HLYK Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, HLYK has a market cap of 10.4M. Regarding current trading prices, GRST is priced at $0.00, while HLYK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas HLYK's P/E ratio is -1.85. In terms of profitability, GRST's ROE is +0.30%, compared to HLYK's ROE of +2.41%. Regarding short-term risk, GRST is less volatile compared to HLYK. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs FPCG Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, GRST is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, GRST's ROE is +0.30%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, GRST and FPCG have similar daily volatility (0.00).
GRST vs GBCS Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, GBCS has a market cap of 9.2M. Regarding current trading prices, GRST is priced at $0.00, while GBCS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas GBCS's P/E ratio is -4.41. In terms of profitability, GRST's ROE is +0.30%, compared to GBCS's ROE of +0.56%. Regarding short-term risk, GRST and GBCS have similar daily volatility (0.00).
GRST vs NUMIF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NUMIF has a market cap of 7.7M. Regarding current trading prices, GRST is priced at $0.00, while NUMIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NUMIF's P/E ratio is -0.39. In terms of profitability, GRST's ROE is +0.30%, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, GRST is less volatile compared to NUMIF. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs XCRT Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, XCRT has a market cap of 7.5M. Regarding current trading prices, GRST is priced at $0.00, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas XCRT's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to XCRT's ROE of +2.48%. Regarding short-term risk, GRST is less volatile compared to XCRT. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs RHEP Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RHEP has a market cap of 7.3M. Regarding current trading prices, GRST is priced at $0.00, while RHEP trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RHEP's P/E ratio is -1.52. In terms of profitability, GRST's ROE is +0.30%, compared to RHEP's ROE of +1.29%. Regarding short-term risk, GRST is less volatile compared to RHEP. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs VLXC Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, VLXC has a market cap of 6.8M. Regarding current trading prices, GRST is priced at $0.00, while VLXC trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas VLXC's P/E ratio is -9.49. In terms of profitability, GRST's ROE is +0.30%, compared to VLXC's ROE of +0.58%. Regarding short-term risk, GRST and VLXC have similar daily volatility (0.00).
GRST vs BICX Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BICX has a market cap of 6.5M. Regarding current trading prices, GRST is priced at $0.00, while BICX trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BICX's P/E ratio is -0.93. In terms of profitability, GRST's ROE is +0.30%, compared to BICX's ROE of +0.40%. Regarding short-term risk, GRST and BICX have similar daily volatility (0.00).
GRST vs RVLWF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, RVLWF has a market cap of 2.7M. Regarding current trading prices, GRST is priced at $0.00, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas RVLWF's P/E ratio is -0.15. In terms of profitability, GRST's ROE is +0.30%, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, GRST and RVLWF have similar daily volatility (0.00).
GRST vs JRSS Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, JRSS has a market cap of 2.7M. Regarding current trading prices, GRST is priced at $0.00, while JRSS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas JRSS's P/E ratio is -0.52. In terms of profitability, GRST's ROE is +0.30%, compared to JRSS's ROE of +2.63%. Regarding short-term risk, GRST and JRSS have similar daily volatility (0.00).
GRST vs EPWCF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, GRST is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, GRST's ROE is +0.30%, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, GRST is less volatile compared to EPWCF. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs SMAS Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, GRST is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas SMAS's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to SMAS's ROE of N/A. Regarding short-term risk, GRST and SMAS have similar daily volatility (0.00).
GRST vs NOVC Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, GRST is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NOVC's P/E ratio is -0.20. In terms of profitability, GRST's ROE is +0.30%, compared to NOVC's ROE of +0.12%. Regarding short-term risk, GRST and NOVC have similar daily volatility (0.00).
GRST vs PHMB Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, GRST is priced at $0.00, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas PHMB's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to PHMB's ROE of N/A. Regarding short-term risk, GRST and PHMB have similar daily volatility (0.00).
GRST vs AMBD Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, AMBD has a market cap of 1M. Regarding current trading prices, GRST is priced at $0.00, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas AMBD's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to AMBD's ROE of +1.11%. Regarding short-term risk, GRST and AMBD have similar daily volatility (0.00).
GRST vs ARPC Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ARPC has a market cap of 1M. Regarding current trading prices, GRST is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ARPC's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to ARPC's ROE of -0.56%. Regarding short-term risk, GRST and ARPC have similar daily volatility (0.00).
GRST vs GNOW Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, GRST is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas GNOW's P/E ratio is -0.01. In terms of profitability, GRST's ROE is +0.30%, compared to GNOW's ROE of +0.00%. Regarding short-term risk, GRST and GNOW have similar daily volatility (0.00).
GRST vs NAFS Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NAFS has a market cap of 700.7K. Regarding current trading prices, GRST is priced at $0.00, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NAFS's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to NAFS's ROE of +1.02%. Regarding short-term risk, GRST is less volatile compared to NAFS. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs MSITF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, GRST is priced at $0.00, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MSITF's P/E ratio is -0.10. In terms of profitability, GRST's ROE is +0.30%, compared to MSITF's ROE of N/A. Regarding short-term risk, GRST and MSITF have similar daily volatility (0.00).
GRST vs NXGT Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NXGT has a market cap of 369.9K. Regarding current trading prices, GRST is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NXGT's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to NXGT's ROE of +0.09%. Regarding short-term risk, GRST and NXGT have similar daily volatility (0.00).
GRST vs DPAT Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, DPAT has a market cap of 361.2K. Regarding current trading prices, GRST is priced at $0.00, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas DPAT's P/E ratio is -1.50. In terms of profitability, GRST's ROE is +0.30%, compared to DPAT's ROE of +0.45%. Regarding short-term risk, GRST and DPAT have similar daily volatility (0.00).
GRST vs JNHMF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, JNHMF has a market cap of 304.1K. Regarding current trading prices, GRST is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas JNHMF's P/E ratio is -0.06. In terms of profitability, GRST's ROE is +0.30%, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, GRST and JNHMF have similar daily volatility (0.00).
GRST vs FCHS Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, FCHS has a market cap of 296.6K. Regarding current trading prices, GRST is priced at $0.00, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas FCHS's P/E ratio is -0.07. In terms of profitability, GRST's ROE is +0.30%, compared to FCHS's ROE of +0.12%. Regarding short-term risk, GRST is less volatile compared to FCHS. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs KJFI Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, KJFI has a market cap of 278.9K. Regarding current trading prices, GRST is priced at $0.00, while KJFI trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas KJFI's P/E ratio is -0.04. In terms of profitability, GRST's ROE is +0.30%, compared to KJFI's ROE of +0.00%. Regarding short-term risk, GRST and KJFI have similar daily volatility (0.00).
GRST vs DRWN Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, DRWN has a market cap of 239.8K. Regarding current trading prices, GRST is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas DRWN's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to DRWN's ROE of -0.01%. Regarding short-term risk, GRST and DRWN have similar daily volatility (0.00).
GRST vs BNYN Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BNYN has a market cap of 150.5K. Regarding current trading prices, GRST is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BNYN's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to BNYN's ROE of -14.10%. Regarding short-term risk, GRST and BNYN have similar daily volatility (0.00).
GRST vs TPIA Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, GRST is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas TPIA's P/E ratio is -0.15. In terms of profitability, GRST's ROE is +0.30%, compared to TPIA's ROE of +0.60%. Regarding short-term risk, GRST is less volatile compared to TPIA. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs ACGI Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ACGI has a market cap of 104.8K. Regarding current trading prices, GRST is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ACGI's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to ACGI's ROE of +1.11%. Regarding short-term risk, GRST and ACGI have similar daily volatility (0.00).
GRST vs SETO Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, SETO has a market cap of 93.6K. Regarding current trading prices, GRST is priced at $0.00, while SETO trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas SETO's P/E ratio is -0.75. In terms of profitability, GRST's ROE is +0.30%, compared to SETO's ROE of +0.00%. Regarding short-term risk, GRST and SETO have similar daily volatility (0.00).
GRST vs SLHGF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, SLHGF has a market cap of 43.8K. Regarding current trading prices, GRST is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas SLHGF's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, GRST and SLHGF have similar daily volatility (0.00).
GRST vs NMHLY Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, GRST is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, GRST's ROE is +0.30%, compared to NMHLY's ROE of N/A. Regarding short-term risk, GRST and NMHLY have similar daily volatility (0.00).
GRST vs PRMD Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, PRMD has a market cap of 37.4K. Regarding current trading prices, GRST is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas PRMD's P/E ratio is -0.01. In terms of profitability, GRST's ROE is +0.30%, compared to PRMD's ROE of +0.73%. Regarding short-term risk, GRST and PRMD have similar daily volatility (0.00).
GRST vs HSMD Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, HSMD has a market cap of 19.2K. Regarding current trading prices, GRST is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas HSMD's P/E ratio is -0.01. In terms of profitability, GRST's ROE is +0.30%, compared to HSMD's ROE of -0.04%. Regarding short-term risk, GRST and HSMD have similar daily volatility (0.00).
GRST vs SCAL Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, GRST is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas SCAL's P/E ratio is 0.04. In terms of profitability, GRST's ROE is +0.30%, compared to SCAL's ROE of +0.07%. Regarding short-term risk, GRST and SCAL have similar daily volatility (0.00).
GRST vs GENN Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, GENN has a market cap of 16.3K. Regarding current trading prices, GRST is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas GENN's P/E ratio is -0.01. In terms of profitability, GRST's ROE is +0.30%, compared to GENN's ROE of +0.00%. Regarding short-term risk, GRST and GENN have similar daily volatility (0.00).
GRST vs CHCR Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, GRST is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas CHCR's P/E ratio is -0.00. In terms of profitability, GRST's ROE is +0.30%, compared to CHCR's ROE of N/A. Regarding short-term risk, GRST and CHCR have similar daily volatility (0.00).
GRST vs CEVE Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, GRST is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas CEVE's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to CEVE's ROE of +2.26%. Regarding short-term risk, GRST and CEVE have similar daily volatility (0.00).
GRST vs NRTSF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NRTSF has a market cap of 7K. Regarding current trading prices, GRST is priced at $0.00, while NRTSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NRTSF's P/E ratio is 0.00. In terms of profitability, GRST's ROE is +0.30%, compared to NRTSF's ROE of +0.00%. Regarding short-term risk, GRST is less volatile compared to NRTSF. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs MSGP Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, GRST is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MSGP's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to MSGP's ROE of +0.27%. Regarding short-term risk, GRST and MSGP have similar daily volatility (0.00).
GRST vs PAOG Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, PAOG has a market cap of 5K. Regarding current trading prices, GRST is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas PAOG's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to PAOG's ROE of +0.08%. Regarding short-term risk, GRST and PAOG have similar daily volatility (0.00).
GRST vs ERUC Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, GRST is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas ERUC's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to ERUC's ROE of N/A. Regarding short-term risk, GRST is less volatile compared to ERUC. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs SLHPF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, GRST is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas SLHPF's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, GRST and SLHPF have similar daily volatility (0.00).
GRST vs WEQL Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, GRST is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas WEQL's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to WEQL's ROE of +0.21%. Regarding short-term risk, GRST and WEQL have similar daily volatility (0.00).
GRST vs BBAL Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, GRST is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BBAL's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to BBAL's ROE of +0.45%. Regarding short-term risk, GRST and BBAL have similar daily volatility (0.00).
GRST vs CLRD Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, CLRD has a market cap of 2.7K. Regarding current trading prices, GRST is priced at $0.00, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas CLRD's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to CLRD's ROE of +0.38%. Regarding short-term risk, GRST and CLRD have similar daily volatility (0.00).
GRST vs NMMCF Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, GRST is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, GRST's ROE is +0.30%, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, GRST is less volatile compared to NMMCF. This indicates potentially lower risk in terms of short-term price fluctuations for GRST.
GRST vs PPRG Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, GRST is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas PPRG's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to PPRG's ROE of -0.58%. Regarding short-term risk, GRST and PPRG have similar daily volatility (0.00).
GRST vs OHAQ Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, GRST is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, GRST's ROE is +0.30%, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, GRST and OHAQ have similar daily volatility (0.00).
GRST vs BNKL Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, GRST is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas BNKL's P/E ratio is N/A. In terms of profitability, GRST's ROE is +0.30%, compared to BNKL's ROE of -7.69%. Regarding short-term risk, GRST and BNKL have similar daily volatility (0.00).
GRST vs MAHN Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, MAHN has a market cap of 1.2K. Regarding current trading prices, GRST is priced at $0.00, while MAHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas MAHN's P/E ratio is 0.05. In terms of profitability, GRST's ROE is +0.30%, compared to MAHN's ROE of N/A. Regarding short-term risk, GRST and MAHN have similar daily volatility (0.00).
GRST vs LHRP Comparison
GRST plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GRST stands at 2.3M. In comparison, LHRP has a market cap of 340. Regarding current trading prices, GRST is priced at $0.00, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GRST currently has a P/E ratio of N/A, whereas LHRP's P/E ratio is 0.00. In terms of profitability, GRST's ROE is +0.30%, compared to LHRP's ROE of N/A. Regarding short-term risk, GRST and LHRP have similar daily volatility (0.00).